PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 200 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,163,000 | +19.0% | 25,664 | 0.0% | 0.03% | +18.2% |
| Q3 2019 | $977,000 | +72.3% | 25,664 | +70.1% | 0.02% | +69.2% |
| Q3 2017 | $567,000 | -10.4% | 15,090 | +13.7% | 0.01% | -7.1% |
| Q2 2017 | $633,000 | -24.8% | 13,269 | -28.1% | 0.01% | -26.3% |
| Q1 2017 | $842,000 | +10.6% | 18,461 | -21.6% | 0.02% | +11.8% |
| Q4 2016 | $761,000 | +286.3% | 23,548 | +309.0% | 0.02% | +325.0% |
| Q3 2016 | $197,000 | +1.5% | 5,757 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $194,000 | -36.4% | 5,757 | 0.0% | 0.00% | -42.9% |
| Q1 2016 | $305,000 | -69.4% | 5,757 | -55.7% | 0.01% | -70.8% |
| Q4 2015 | $997,000 | – | 12,989 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |